Product

Enobosarm & Abemaciclib Combo

Aliases

VERU-024, Verzenio

1 clinical trial

1 indication

Indication

Clinical trial

P3 Efficacy Evaluation of Enobosarm in Combo With Abemaciclib Compared to Estrogen Blocking Agent for 2nd Line Treatment of ER+HER2- MBC in Patients Who Have Shown Previous Disease Progression on an Estrogen Blocking Agent Plus Palbociclib

Status: Terminated, Estimated PCD: 2023-10-19